Publications
Crystallization and preliminary X-ray diffraction analysis of kanamycin-binding β-lactamase in complex with its ligand Vrije Universiteit Brussel
A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines Vrije Universiteit Brussel
Crystal structure of a cold-adapted class C-beta lactamase Vrije Universiteit Brussel
Presence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in waste waters, Kinshasa, the Democratic Republic of the Congo Institute of Tropical Medicine
α‐Unsaturated 3‐Amino‐1‐carboxymethyl‐β‐lactams as bacterial PBP inhibitors : synthesis and biochemical assessment Ghent University
Causative agents of bloodstream infections in two Croatian hospitals and their resistance mechanisms Hasselt University Ghent University
Effect of U+03B2-lactamase inhibitors on in vitro activity of U+03B2-lactam antibiotics against Burkholderia cepacia complex species Ghent University
Characterization of ESBL-producing Salmonella enterica serovar infantis infection in humans, Lima, Peru Institute of Tropical Medicine KU Leuven
Salmonella enterica serovar Infantis is causing an increasing number of infections worldwide. Our aim was to describe the characteristics of S. enterica serovar Infantis among patients attended in a hospital of Lima, Peru. Fifty cases of salmonellosis were seen during October 2015-May 2017; Salmonella Infantis was detected in 36% (n = 18) of them, displacing Enteritidis and Typhimurium (n = 13, 26%, each). Seventeen cases caused by Salmonella ...
An African Salmonella Typhimurium ST313 sublineage with extensive drug-resistance and signatures of host adaptation Institute of Tropical Medicine KU Leuven University of Antwerp
Bloodstream infections by Salmonella enterica serovar Typhimurium constitute a major health burden in sub-Saharan Africa (SSA). These invasive non-typhoidal (iNTS) infections are dominated by isolates of the antibiotic resistance-associated sequence type (ST) 313. Here, we report emergence of ST313 sublineage II.1 in the Democratic Republic of the Congo. Sublineage II.1 exhibits extensive drug resistance, involving a combination of multidrug ...